PATENT CLAIM ANALYSIS

Application Number: 16127560
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "019200"]

Abstract:
Disclosed herein are stabilized formulations of carfilzomib. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.

Claim (Index 38):
The method according to  claim 31 , wherein the composition is ready-to-use and is directly injected into the patient.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15796021', '14023247', '15342457', '15824557', '13592228']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7318185200466163
- 35 USC 102 Novelty (BERT): 0.5429242754266242
- Combined Prediction Score: 0.712929095584617
- Mean Citation Score: 228.586866
- Max Citation Score: 363.3687
- Similarity Product: 233.71066206028465

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test